Full-Time

Associate Director

Marketing Communications & Business Development

Posted on 2/21/2025

Becton Dickinson

Becton Dickinson

10,001+ employees

Medical technology for diagnostics and care

Healthcare

Senior, Expert

Durham, NC, USA + 1 more

More locations: San Diego, CA, USA

Candidates must be available to work onsite 4 days per week in our BD offices: Preferred Raleigh/Durham, NC with the secondary option of San Diego, CA.

Category
Business Development
Business & Strategy
Required Skills
Communications
Marketing

You match the following Becton Dickinson's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor's degree in business or communications required; Master's degree preferred
  • Must have 10 years of marketing experience preferably in medical device/pharma industry, ideally including various marketing roles, global and regional
  • 5 years of direct people manager experience
  • Consistent track record of high performance and results
  • Demonstrated critical thinking to plan impactful communications in the field, bringing recommendations on how to demonstrate communication channels
  • Excellent written and verbal communication skills and interpersonal skills
  • Experience in digital marketing and tradeshow strategy and planning
  • Able to travel up to 20% of the time (e.g. Domestic tradeshows, customer events and team meetings)
Responsibilities
  • Developing and leading the creation and execution of the external product and solution communication and omni-channel strategy
  • Creating impactful content to the market focused on products, solutions and relevant topics that demonstrate BD’s knowledge, leadership, expertise, capabilities and solutions
  • Translating marketing tactics into integrated programs and campaigns, engaging and cultivating customers throughout their buying journey
  • Advising, leading and execution of marketing communications and campaigns across public relations, tradeshows, campaigns, digital channels (website, social, search…)
  • Creating content on strategic products and topics for publication and sharing by associates
  • Responsible for the promotional publication strategy for strategic product and solution topics
  • Driving consistent, repeatable, efficient, and impactful demand creation activities across all the regions
  • Designing and completing global multi-year strategy and programs, and optimizing demand creation approaches across the organization
  • Leading a team made up of marketing communications managers, content strategists and a business development (DemandGen) manager

Becton Dickinson (BD) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on solutions for medication management and delivery; BD Life Sciences, which offers products for the safe collection and transport of diagnostic specimens; and BD Interventional, which provides devices for minimally invasive surgeries. BD generates revenue by selling medical devices, laboratory equipment, and diagnostic products. The company stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare environments.

Company Size

10,001+

Company Stage

IPO

Total Funding

$449.4K

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...